IBRX ImmunityBio Inc

$IBRX Short interest dropped 1.3 million shares in last report. Short interest down 10 million shares since July 15th. Hedgies have lost a fortune. Still if they had to cover at this pace it will take years to cover. This rise we are seeing is in the very early stages. Thank you hedgies for your unbelievable gift of wealth transferred to me and thousands of other longs. Dr. Pat you get tremendous credit.

$IBRX if you're here you must read this. New cancer panel appointee has been focused in on Anktiva patients and engaging with them. Think about this....

$IBRX $20 pps by EOY or when bladder papillary is approved (PDUFA 01/06/27) - whichever comes first. $40 pps by EOY 2027 or when bladder BCG-naive sBLA filing is approved, whichever comes first -(stat data assumed stellar when announced this qtr and IBRX subsequent filing anticipated during 4th qtr 2026). Now throw in all of the multiple unknown catalysts coming between now and EOY ‘27. Domestically, and abroad. Dozens of moving parts/trials in motion. Cannot feel more stoked on where IBRX is heading. All imo, but many Longs here share the same sentiment. For the novice retail aboard, research your own dd. You owe it to yourself. Back to Halloween outdoor decorations! GL$$$$😎

$IBRX I’m looking at $50 by February. Two more earnings reports and the second Anktiva approval on January 6. Q3 numbers early November. Papillary PDUFA January 6. Then the Q4 / full-year print in February that should start reflecting the bigger label. Q2 already delivered a record $50.7 million in product revenue — up 92% and the eighth straight quarter of sequential growth. First half sat at $94.8 million. Global footprint is at 34 countries. The commercial foundation is already working. Dr. Patrick has been building this for a decade. Anktiva is the backbone. The label expansion is the multiplier that opens the larger patient pool. This is the cleanest setup we’ve had. #IBRX #ANKTIVA #CancerBioShield 🚀

$IBRX watching IBRX getting sidelined by the FDA is like watching your kid play soccer and the ref was born and raised in the competitor teams hometown. Just bull sh*t The true winner will be coming to light soon. Release Anktiva!

$IBRX So did I miss something, or is Dr Soon-Shiong’s NIH/CDC speech still embargoed? Yeah, something is cooking. My guess, a multi-Country Cancer Moonshot to be launched. IBRX,$PDSB & $NWBO….who else? MRNA & LLY….blahhhhh! Saudi, Turkey, Japan, UAE, Portugal, Greece, UK… Anktiva+NK+CPI+KRAS+IL-12+ Adenovirus+Own Tumor Lysate+Senovax Add Vitamin D, Intravenous C, Anti Parasitics Cancer stands NO chance! Not to mention new Press Secretary is tight with Caputo, Mills, and other PSS fans! Yeah, a Cancer Kiliing ‘Orchestra’ ….not a lame combo!

$IBRX ~ The Piper meeting friday is only scheduled for 25 minutes . We should news before then as it's hard to update all the trials and other events in 25 minutes. 1L bladder trial for sure and I'm thinking the lung cancer update will be more than statistically significant. The chart looks great , looking like $15 and a new trading range , once it breaks through $12.5. My rating is still a strong buy

$IBRX Just had the highest weekly close since August 2021. Price is trying to breakout of one-week cup high of $10.76. Longer term cup breakout point at $12.16. Any positive news on current known catalysts will easily challenge the $12.16 level. Great news will send it to $15. Regardless, Q2 2027 will likely be between $30 and $40 if expected catalysts are achieved. Exceptional news beyond known catalyst, then it's anybody's guess up to $100.

$IBRX Short interest plummeting. Shorts are looking for the exits. I think they are going to drive this up over $40 soon!!!!

$IBRX shorts continue to take on water, they were already drowning a month ago when we were trading at 7.50 and they've only covered less than 2m shares since. Now it's being slowly accumulated above 10.50 and they still have 124m short!! Light the fuse!!!🤣🤣🤣 🔥🚀🚀🚀

$IBRX It’s gonna be a very interesting week : 👉🏼Rumor $IBRX in NIH cancer vaccine? 👉🏼Turkey announcement 🦃? 👉🏼Preliminary Q3 beat? 👉🏼Dr.Pat trials status updates with Piper Sandler Oncology Symposium on Friday Oct 16th at 10:00 pst (OPEX) and check out the open interest on the $12 calls 11000 contracts👇. SP on Friday needs to be way deep ITM for the $12 calls to be profitable 🤞. Our good Dr. Pat seems very excited and confident on his X post about his updates on the trials. Timing is everything!! Let’s see who can outsmart who? My money is with our billionaire doctor. 🍿🍿💥💥

$IBRX $PDSB Great day today fam! Time for a little celebration, Cheers! Have a great weekend! Looking forward to another profitable week.

$IBRX Another beautiful dawn of a new day! A precursor to a beautiful week ahead for IBRX, its patients, and Long investors. Enjoy your Sunday. Go Bears!! 🏈 🍻

$IBRX YUP I’D SAY IBRX IS IN THE SWEET SPOT! I don’t subscribe to NY Times but this is the article that moved all the vax players yesterday. IBRX should have been up 10% like IOVA and NVAX. Just wait until the street connects the dots with our Lynch Syndrome vaccine sponsored by NCI. IBRX has been working on Lynch with NCI for over a decade. IBRX is ahead of the game compared to the names that were bid up yesterday bc of this article.

$IBRX This has turned out to be great fun. All I ever needed from this to have a very comfortable life is $30PPS. And we will be blowing way past that! I am a somewhat basic person. WTF will I do with all this? But it is so much fun.

$IBRX “This is curable” He meant to say with his Anktiva!!! But the corrupt FDA would be all over him with more warning letters 💯

$IBRX my 1 year anniversary is coming Since I bought in. 5 year retirement plan. So glad to be here with you bulls!

$IBRX — Yesterday I had a video visit with one of my UCLA doctors and I decided to ask if he could tell me what is my absolute lymphocyte count. I was amazed and impressed that he was able to rattle off my ALC from three different points over the past 3 years. It was good to know that at UCLA, ALC matters!

$IBRX Michael people with low ALC's their cancers are reoccurring! What are you and the Presidential Cancer panel doing to get ANKTIVA approved for this? Please update us!

$IBRX - Great week again guys. Next week looks like it could be interesting. Dr Pat says he is going to give an update on trials, at the fire side chat. Let's be honest - you wouldn't brag about it if the update was bad. Let's hope it blows everyone's socks off! Have a great weekend my fellow long brothers and sisters (I am currently on holiday in Grand Caneria enjoying the Sun)